Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000557EBVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20001603HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20029318HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20031248HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TCGA Plot Options
Drug Information
GeneSLC6A4
DrugBank IDDB01191
Drug NameDexfenfluramine
Target IDBE0000749
UniProt IDP31645
Regulation Typeinhibitor
PubMed IDs11259539; 11325413; 14515341; 14675103; 15266556
CitationsEddahibi S, Adnot S, Frisdal E, Levame M, Hamon M, Raffestin B: Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J Pharmacol Exp Ther. 2001 Apr;297(1):148-54.@@Russell BR, Laverty R: The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity. Pharmacol Biochem Behav. 2001 Mar;68(3):565-74.@@Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH: High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse. 2003 Dec 1;50(3):233-9.@@Johnson GJ, Leis LA, Dunlop PC, Weir EK: The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. J Thromb Haemost. 2003 Dec;1(12):2663-8.@@Wang X, Baumann MH, Xu H, Rothman RB: 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse. 2004 Sep 15;53(4):240-8.
GroupsApproved; Illicit; Investigational; Withdrawn
Direct ClassificationAmphetamines and derivatives
SMILESCCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F
Pathways
PharmGKBPA164747936
ChEMBLCHEMBL248702